Dr. Jane
January 22, 2022
Consumer Medicine Information (CMI) summary The full CMI on the next page has more details. If you are worried about taking this medicine, speak to your doctor or pharmacist. This is a new medicine. Please report any side effects that you may experience with this medicine. See the full CMI for further details. Why am I taking LAGEVRIO? Read morePurdue …
Dr. Jane
November 2, 2021
Canalevia ™ -CA1 is the first and only oral prescription herbal drug candidate for CID in dogsJaguar launches awareness-raising competition in honor of International Jaguar Day; click here enter SAN FRANCISCO, CA / ACCESSWIRE / November 2, 2021 / Jaguar Health, Inc. (NASDAQ: JAGX) announced today that the filing of the New Animal Drug Application (NADA) has been completed to …
Dr. Jane
November 1, 2021
Consumer Medicine Information (CMI) summary The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Read moreUnexpected Growth Seen in Companion Animal External Medicine Market from 2021 to 2026 This medicine is new or being used differently. Please report side effects. See the full …
MONDAY, Aug 23, 2021 (HealthDay News) – Taking a drug for horses and cattle to prevent or treat COVID-19 is dangerous and could be fatal, warns the U.S. Food and Drug Administration. The agency has received several reports of people being hospitalized after “self-medication with ivermectin for horses,” the agency said in a consumer update. Ivermectin, which is not an …
Dr. Jane
September 20, 2021
September 20, 2021, 9:28 pm Zoetis, the maker of Cerenia, an injectable drug used to treat severe vomiting in cats and dogs, alleged in a lawsuit that Dechra’s generic version, Emavert, infringed a patent. Zoetis is seeking an injunction preventing Dechra from manufacturing its product until the patent expires and cash compensation if it is done before that time, according …
Dr. Jane
September 19, 2021
Organs-on-Chips could be used to evaluate the effectiveness of drugs and to support personalized medicine, write Adrian Roth and colleagues in a perspective. “The decisive advantage The offer is the creation of physiologically more relevant human organ-like models that can potentially provide data on drug effects that can be better transferred to humans than those from in vivo animal models …
Cardiology Evkeeza (evinacumab) Evinacumab is a recombinant human monoclonal antibody that binds to and inhibits angiopoietin–like 3 (ANGPTL3). ANGPTL3 inhibits lipoprotein lipase and endothelial lipase, thereby reducing lipid metabolism. Evinacumab inhibits ANGPTL3 and results in increased lipid metabolism, leading to decreased low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, and triglycerides. Evinacumab is indicated as an adjunct to other LDL-C–lowering therapies …
DUBLIN, Aug 18, 2021 – (BUSINESS WIRE) – The Veterinary Drug Approval Process and FDA Regulatory Oversight conference has been added to ResearchAndMarkets.com offer. This two-day interactive online seminar provides attendees with an understanding of the FDA’s 2021 approval process for veterinary drugs. The U.S. Food and Drug Administration’s (CVM) Center for Veterinary Medicine (CVM) is responsible for approving veterinary …
The Reports Globe on the Global trade report Cyromazine Drug Market aims to provide a deep understanding of the definition, potential and scope of the market. The report is prepared by experts after extensive research and analysis. It consists of an organized and methodical explanation of current market trends to allow users to have a thorough analysis of the market. …
DUBLIN – (BUSINESS WIRE) – “The Veterinary Drug Approval Process and FDA Regulatory Oversight” training has been added ResearchAndMarkets.com offer. The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for approving veterinary drugs for pets, food-producing animals, and other species. This seminar covers the process of obtaining federal government approval to commercialize new veterinary drugs that …
